• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过人群归因风险分析确定美国艰难梭菌感染风险最高的医疗保险受益人群。

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.

作者信息

Dubberke Erik R, Olsen Margaret A, Stwalley Dustin, Kelly Ciarán P, Gerding Dale N, Young-Xu Yinong, Mahé Cedric

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, United States of America.

出版信息

PLoS One. 2016 Feb 9;11(2):e0146822. doi: 10.1371/journal.pone.0146822. eCollection 2016.

DOI:10.1371/journal.pone.0146822
PMID:26859403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4747338/
Abstract

BACKGROUND

Population attributable risk percent (PAR%) is an epidemiological tool that provides an estimate of the percent reduction in total disease burden if that disease could be entirely eliminated among a subpopulation. As such, PAR% is used to efficiently target prevention interventions. Due to significant limitations in current Clostridium difficile Infection (CDI) prevention practices and the development of new approaches to prevent CDI, such as vaccination, we determined the PAR% for CDI in various subpopulations in the Medicare 5% random sample.

METHODS

This was a retrospective cohort study using the 2009 Medicare 5% random sample. Comorbidities, infections, and healthcare exposures during the 12 months prior to CDI were identified. CDI incidence and PAR% were calculated for each condition/exposure. Easy to identify subpopulations that could be targeted from prevention interventions were identified based on PAR%.

FINDINGS

There were 1,465,927 Medicare beneficiaries with 9,401 CDI cases for an incidence of 677/100,000 persons. Subpopulations representing less than 15% of the entire population and with a PAR% ≥ 30% were identified. These included deficiency anemia (PAR% = 37.9%), congestive heart failure (PAR% = 30.2%), fluid and electrolyte disorders (PAR% = 29.6%), urinary tract infections (PAR% = 40.5%), pneumonia (PAR% = 35.2%), emergent hospitalization (PAR% = 48.5%) and invasive procedures (PAR% = 38.9%). Stratification by age and hospital exposures indicates hospital exposures are more strongly associated with CDI than age.

SIGNIFICANCE

Small and identifiable subpopulations that account for relatively large proportions of CDI cases in the elderly were identified. These data can be used to target specific subpopulations for CDI prevention interventions.

摘要

背景

人群归因风险百分比(PAR%)是一种流行病学工具,用于估计如果某疾病能在亚人群中完全消除,总疾病负担将降低的百分比。因此,PAR%用于有效定位预防干预措施。由于当前艰难梭菌感染(CDI)预防措施存在重大局限性,且出现了如疫苗接种等预防CDI的新方法,我们在医疗保险5%随机样本中确定了不同亚人群中CDI的PAR%。

方法

这是一项使用2009年医疗保险5%随机样本的回顾性队列研究。确定CDI发生前12个月内的合并症、感染和医疗暴露情况。计算每种疾病/暴露情况的CDI发病率和PAR%。根据PAR%确定易于识别的、可作为预防干预目标的亚人群。

结果

有1,465,927名医疗保险受益人,其中9,401例CDI病例,发病率为677/100,000人。确定了占总人口不到15%且PAR%≥ 30%的亚人群。这些包括缺铁性贫血(PAR% = 37.9%)、充血性心力衰竭(PAR% = 30.2%)、体液和电解质紊乱(PAR% = 29.6%)尿路感染(PAR% = 40.5%)、肺炎(PAR% = 35.2%)、急诊住院(PAR% = 48.5%)和侵入性操作(PAR% = 38.9%)。按年龄和医院暴露分层表明,医院暴露与CDI的关联比年龄更强。

意义

确定了在老年人中占CDI病例比例相对较大的、规模小且可识别的亚人群。这些数据可用于针对特定亚人群进行CDI预防干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ab323043101f/pone.0146822.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/f59cfb144ad6/pone.0146822.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ef3de7e260bd/pone.0146822.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ca06e104197d/pone.0146822.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ab323043101f/pone.0146822.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/f59cfb144ad6/pone.0146822.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ef3de7e260bd/pone.0146822.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ca06e104197d/pone.0146822.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd87/4747338/ab323043101f/pone.0146822.g004.jpg

相似文献

1
Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.通过人群归因风险分析确定美国艰难梭菌感染风险最高的医疗保险受益人群。
PLoS One. 2016 Feb 9;11(2):e0146822. doi: 10.1371/journal.pone.0146822. eCollection 2016.
2
Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study.2011年长期护理机构老年居民中艰难梭菌感染的患病率及影响:一项全国性研究
Medicine (Baltimore). 2016 Aug;95(31):e4187. doi: 10.1097/MD.0000000000004187.
3
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.艰难梭菌感染的负担:来自美国行政数据库的艰难梭菌感染发病率估计
BMC Infect Dis. 2016 Apr 22;16:177. doi: 10.1186/s12879-016-1501-7.
4
Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.老年人艰难梭菌感染的死亡率、医疗保健利用及费用
J Am Med Dir Assoc. 2022 Oct;23(10):1721-1728.e19. doi: 10.1016/j.jamda.2022.01.075. Epub 2022 Mar 11.
5
Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study.美国东南部社区相关艰难梭菌感染的负担:一项基于人群的研究。
Infection. 2020 Feb;48(1):129-132. doi: 10.1007/s15010-019-01368-5. Epub 2019 Nov 1.
6
Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.美国老年人艰难梭菌感染的死亡率和成本
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1331-1336. doi: 10.1017/ice.2016.188. Epub 2016 Aug 30.
7
Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.基于发病时间设定的艰难梭菌感染所致成本。
Clin Infect Dis. 2023 Mar 4;76(5):809-815. doi: 10.1093/cid/ciac841.
8
Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce infection rates.在医疗体系中实施有针对性的评估预防策略,以降低感染率。
Infect Control Hosp Epidemiol. 2020 Mar;41(3):295-301. doi: 10.1017/ice.2019.358. Epub 2020 Jan 13.
9
Identification of target risk groups for population-based Clostridium difficile infection prevention strategies using a population attributable risk approach.采用人群归因风险方法识别基于人群的艰难梭菌感染预防策略的目标风险人群。
Int J Infect Dis. 2018 Jan;66:107-112. doi: 10.1016/j.ijid.2017.11.021. Epub 2017 Nov 21.
10
Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.养老院患者中艰难梭菌相关疾病的负担:一项基于人群的队列研究。
BMC Geriatr. 2016 Nov 25;16(1):193. doi: 10.1186/s12877-016-0367-2.

引用本文的文献

1
First-Trimester Antibiotic Use for Urinary Tract Infection and Risk of Congenital Malformations.孕早期使用抗生素治疗尿路感染与先天性畸形风险
JAMA Netw Open. 2025 Jul 1;8(7):e2519544. doi: 10.1001/jamanetworkopen.2025.19544.
2
Comparative safety of different antibiotic regimens for the treatment of outpatient community-acquired pneumonia among otherwise healthy adults.不同抗生素治疗方案用于治疗健康成人门诊社区获得性肺炎的比较安全性
Clin Infect Dis. 2024 Oct 23. doi: 10.1093/cid/ciae519.
3
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection.

本文引用的文献

1
A history of the population attributable fraction and related measures.人口归因分数及相关措施的历史。
Ann Epidemiol. 2015 Mar;25(3):147-54. doi: 10.1016/j.annepidem.2014.11.015. Epub 2014 Dec 11.
2
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
3
The prospect for vaccines to prevent Clostridium difficile infection.预防艰难梭菌感染的疫苗前景。
三叶草(艰难梭菌疫苗疗效试验)研究:一项3期随机试验,调查一种脱毒毒素A/B疫苗在50岁及以上艰难梭菌感染风险增加的成年人中的疗效和安全性。
Clin Infect Dis. 2024 Dec 17;79(6):1503-1511. doi: 10.1093/cid/ciae410.
4
": The Epidemiology of Toxigenic Strains in the Antibiotic Era-Insights from a Prospective Study at a Regional Infectious Diseases Hospital in Eastern Europe.:抗生素时代产毒菌株的流行病学——来自东欧一家地区传染病医院前瞻性研究的见解。
Antibiotics (Basel). 2024 May 17;13(5):461. doi: 10.3390/antibiotics13050461.
5
Utilization of broad- versus narrow-spectrum antibiotics for the treatment of outpatient community-acquired pneumonia among adults in the United States.美国成年人门诊获得性肺炎治疗中,广谱抗生素与窄谱抗生素的使用。
Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5779. doi: 10.1002/pds.5779.
6
Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive Bloodstream Infections: Results From a Large United States Claims Database.头孢曲松与头孢唑林或萘夫西林/苯唑西林用于门诊治疗甲氧西林敏感血流感染的疗效比较:来自美国大型索赔数据库的结果
Open Forum Infect Dis. 2024 Jan 12;11(2):ofad662. doi: 10.1093/ofid/ofad662. eCollection 2024 Feb.
7
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.美国艰难梭菌感染的危险因素及发生时间的系统文献综述
Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13.
8
Comparative Safety and Attributable Healthcare Expenditures Following Inappropriate Versus Appropriate Outpatient Antibiotic Prescriptions Among Adults With Upper Respiratory Infections.成人上呼吸道感染患者中,不适当与适当门诊抗生素处方的比较安全性和可归因医疗费用。
Clin Infect Dis. 2023 Mar 21;76(6):986-995. doi: 10.1093/cid/ciac879.
9
Prevalence and risk factors associated with readmission with acute kidney injury in patients receiving vancomycin outpatient parenteral antimicrobial therapy.接受万古霉素门诊肠外抗菌治疗的患者中,急性肾损伤再入院的患病率及相关风险因素。
J Clin Pharm Ther. 2022 Dec;47(12):2188-2195. doi: 10.1111/jcpt.13790. Epub 2022 Oct 18.
10
Trends in the incidence of infection in adults and the elderly insured by Medicaid compared to commercial insurance or Medicare only.比较 Medicaid 保险覆盖的成年人和老年人与仅商业保险或医疗保险覆盖的成年人和老年人的 感染发病率趋势。
Infect Control Hosp Epidemiol. 2023 Jul;44(7):1076-1084. doi: 10.1017/ice.2022.208. Epub 2022 Sep 9.
Infect Dis Clin North Am. 2015 Mar;29(1):145-62. doi: 10.1016/j.idc.2014.11.013.
4
Multistate point-prevalence survey of health care-associated infections.多州医疗机构相关性感染的时点患病率调查。
N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.
5
Accuracy of administrative code data for the surveillance of healthcare-associated infections: a systematic review and meta-analysis.行政代码数据在监测医疗相关性感染中的准确性:系统评价和荟萃分析。
Clin Infect Dis. 2014 Mar;58(5):688-96. doi: 10.1093/cid/cit737. Epub 2013 Nov 11.
6
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.社区获得性艰难梭菌感染的流行病学,2009 年至 2011 年。
JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.
7
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.冠状动脉旁路移植术后万古霉素辅助抗生素预防与艰难梭菌感染的风险。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):472-8. doi: 10.1016/j.jtcvs.2013.02.075. Epub 2013 Mar 28.
8
Burden of Clostridium difficile on the healthcare system.艰难梭菌对医疗体系的负担。
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S88-92. doi: 10.1093/cid/cis335.
9
Clostridium difficile infection, Colorado and the northwestern United States, 2007.艰难梭菌感染,科罗拉多州和美国西北部,2007 年。
Emerg Infect Dis. 2012 Jun;18(6):960-2. doi: 10.3201/eid1806.111528.
10
Vital signs: preventing Clostridium difficile infections.生命体征:预防艰难梭菌感染。
MMWR Morb Mortal Wkly Rep. 2012 Mar 9;61(9):157-62.